How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.
about
Clitocine reversal of P-glycoprotein associated multi-drug resistance through down-regulation of transcription factor NF-κB in R-HepG2 cell lineAltered intracellular localization and mobility of SBDS protein upon mutation in Shwachman-Diamond syndromeHostile takeovers: viral appropriation of the NF-kB pathwayTransactivation of naturally occurring HIV-1 long terminal repeats by the JNK signaling pathway. The most frequent naturally occurring length polymorphism sequence introduces a novel binding site for AP-1 factorsNF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cellsIKKβ phosphorylation regulates RPS3 nuclear translocation and NF-κB function during infection with Escherichia coli strain O157:H7Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathwaysNegative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunitPositive regulation of IkappaB kinase signaling by protein serine/threonine phosphatase 2AHyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cellsRIP2, a checkpoint in myogenic differentiation.CARMA1 is required for Akt-mediated NF-kappaB activation in T cells.Identification of a human NF-kappaB-activating protein, TAB3The oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-kappaB signaling downstream of TRAF2Extracellular Release and Signaling by Heat Shock Protein 27: Role in Modifying Vascular InflammationMolecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and β-Cell DysfunctionNew drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)Cancer prevention with promising natural products: mechanisms of action and molecular targetsHepatitis C virus nonstructural 5B protein regulates tumor necrosis factor alpha signaling through effects on cellular IkappaB kinaseICOS Co-Stimulation: Friend or Foe?Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB.SIMPL is a tumor necrosis factor-specific regulator of nuclear factor-kappaB activityNegative regulation of the nuclear factor kappa B-inducing kinase by a cis-acting domainThe Rel/NF-kappaB signal transduction pathway: introductionActivation of IKKalpha and IKKbeta through their fusion with HTLV-I tax proteinRole of IKKgamma/nemo in assembly of the Ikappa B kinase complexPhorbol esters and cytokines regulate the expression of the NEMO-related protein, a molecule involved in a NF-kappa B-independent pathwayNucleolar sequestration of RelA (p65) regulates NF-kappaB-driven transcription and apoptosisIdentification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2Protein phosphatase 2Cbeta association with the IkappaB kinase complex is involved in regulating NF-kappaB activityActivation of the RON receptor tyrosine kinase by macrophage-stimulating protein inhibits inducible cyclooxygenase-2 expression in murine macrophagesPhysical and functional interaction of CARMA1 and CARMA3 with Ikappa kinase gamma-NFkappaB essential modulatorA functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetesNuclear factor-kappa B activation in human testicular apoptosisActivity of hepatocyte nuclear factor 1alpha and hepatocyte nuclear factor 1beta isoforms is differently affected by the inhibition of protein phosphatases 1/2ASoluble epoxide hydrolase inhibitors and heart failureAdaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous systemNFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progressionBeneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approachesNitrosylcobalamin potentiates the anti-neoplastic effects of chemotherapeutic agents via suppression of survival signaling
P2860
Q21134144-8B915727-DEFF-4B4E-B17C-A2E373A87DCFQ21135349-09434332-E2A3-4EB7-AA3D-B739052CA23AQ22241900-97172B52-B689-4BD9-A5E1-C4EBC9783F5FQ22253886-9080A644-F00E-4B25-836E-E89D6A067E19Q22254088-DDB62B96-C5B1-4A7C-BC3D-C33F02E73216Q24297066-FE48A42E-746F-47DD-BA9A-5749C5B9CD80Q24302300-7BDDFA73-5E8A-491F-BB5F-C2E4BBC86180Q24317508-54BD9A22-EFF9-45B4-8E84-8289A581734DQ24318289-27594A9E-13CB-4E4E-9DAE-87ECC5E165F2Q24319922-1D7A91C7-57F4-4ABB-AFB1-040C467700D7Q24537698-BFDA8E0F-6E83-44B4-87A6-78E52FF62244Q24548028-3356A332-6F17-4AB3-8B79-5B6E81225EF5Q24621651-39C64A4C-D78F-485D-8C65-E23470ACDBA3Q24674848-1B2150C9-551D-4C28-805A-1DA411C3B673Q26738276-96CA2322-CE6D-4F60-BF12-7AE2A803618BQ26800081-6F4F189C-F2B4-4147-884F-867F85DF5695Q27004421-DFEE8803-9111-4391-A993-11F5FA5AABC4Q27006530-7EA81A5F-55B7-41A7-BC8B-40D017E0A1D6Q27473152-1245BF31-8468-48CA-A45D-C4C2D12BD552Q28072305-C7E90988-73F3-427C-8C8A-7DB89241B29FQ28118359-A4E30AAA-7A8F-41A9-B1CC-E8A99C52D4F2Q28138811-20A10AD4-F9C2-4129-BD3D-52D593F77A5AQ28140339-896D1B5A-C2B8-4351-9735-D34B47C22269Q28140718-B76130F8-847B-4727-AAD4-DCC4B255D80EQ28143127-7346E34D-192B-44F4-9376-BC9994A0416DQ28143953-BE01FEAA-49D7-400B-AFAF-39D042EBA4DFQ28144297-057E6935-956A-47ED-9FA1-12E5273B9522Q28182225-F6809600-46B3-46D5-A14D-44B0FF723B44Q28199348-02715DEF-14F2-4FCC-8907-127FB61B1836Q28213409-7689D514-0A31-4600-AEF0-6C79FC56F31FQ28217885-5D7339D3-E458-4AB6-9483-E1372B32F54BQ28265675-4269DD6F-7079-4983-8D3D-7B43FBB56BAEQ28271534-D0C24746-0A4F-4FFA-8C11-1990459F6DACQ28344806-6B5E0A61-B60B-4875-A470-7D71C7E570CEQ28348306-0556464D-3B69-4C1C-BE18-324EEE16C7F4Q28383423-B1DD0A3A-239E-48A3-BB4A-6CC96F994C21Q28389419-4E45197C-C1B7-491D-99B8-6CDE3F27D41DQ28390763-E9C4C9E5-AB88-4CB7-9D3E-A24F4507F8C6Q28397084-F3ED4A54-3BF4-401E-87C4-974210069B11Q28471740-5A5BA92B-F629-4302-BF45-20F4EFA20EAB
P2860
How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.
@ast
How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.
@en
type
label
How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.
@ast
How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.
@en
prefLabel
How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.
@ast
How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.
@en
P2860
P356
P1433
P1476
How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1203219
P407
P577
1999-11-01T00:00:00Z
P5875
P6179
1050806091